Evidence map›Paper›PMID 24309508›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2014

Development of DNA damage response signaling biomarkers using automated, quantitative image analysis.

Nana Nikolaishvilli-Feinberg, Stephanie M Cohen, Bentley Midkiff, Yingchun Zhou, Mark Olorvida, Joseph G Ibrahim, Bernard Omolo, Janiel M Shields, Nancy E Thomas, Pamela A Groben and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  6. Article
  7. Article
  8. IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2015
    Article
  9. Mechanisms of chromosomal instability in melanoma.Environmental and molecular mutagenesis · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution.

Nana Nikolaishvilli-FeinbergTranslational Pathology Laboratory (NNF, SMC, BM, MO, CRM), University of North Carolina School of Medicine, NC, USA.
Stephanie M Cohen
Bentley Midkiff
Yingchun Zhou
Mark Olorvida
Joseph G Ibrahim
Bernard Omolo
Janiel M Shields
Nancy E Thomas
Pamela A Groben
William K Kaufmann
C Ryan Miller
UNC Lineberger Comprehensive Cancer Center

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Tissue Procurement & PathologyP50CA058223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KATHERINE A. HOADLEY · 1992 to 2026
$59.3M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
TOXICOLOGYT32ES007126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ILONA JASPERS, Bernard E. Weissman · 1985 to 2026
$13.0M
TISSUE PROCUREMENT &ANALYSISP50CA106991 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TEPPER, JOEL E · 2004 to 2009
$12.1M
The System of Response to DNA Damage Suppresses Environmental MelanomagenesisP01ES014635 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SANCAR, AZIZ · 2007 to 2011
$6.7M
Melanoma RAS/BRAF Mutation:Heterogeneity-Risk-PrognosisR01CA112243 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THOMAS, NANCY E. · 2005 to 2014
$5.4M
Biostatistics for Research in Genomics and CancerT32CA106209 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOSEPH G IBRAHIM, Naim Ur Rashid · 2004 to 2026
$4.8M
NCI NIH HHS CA016086NCI NIH HHS CA058223NCI NIH HHS CA106991NCI NIH HHS CA10704339NCI NIH HHS CA112243NCI NIH HHS P30 CA016086NCI NIH HHS P50 CA058223NCI NIH HHS P50 CA106991NCI NIH HHS R01 CA112243NCI NIH HHS T32 CA106209NIEHS NIH HHS ES010126NIEHS NIH HHS ES014635NIEHS NIH HHS ES07126NIEHS NIH HHS P01 ES014635NIEHS NIH HHS P30 ES010126NIEHS NIH HHS T32 ES007126
6 · The paper itself

Abstract

The DNA damage response (DDR) coordinates DNA repair with cell cycle checkpoints to ameliorate or mitigate the pathological effects of DNA damage. Automated quantitative analysis (AQUA) and Tissue Studio are commercial technologies that use digitized immunofluorescence microscopy images to quantify antigen expression in defined tissue compartments. Because DDR is commonly activated in cancer and may reflect genetic instability within the lesion, a method to quantify DDR in cancer offers potential diagnostic and/or prognostic value. In this study, both AQUA and Tissue Studio algorithms were used to quantify the DDR in radiation-damaged skin fibroblasts, melanoma cell lines, moles, and primary and metastatic melanomas. Digital image analysis results for three markers of DDR (γH2AX, P-ATM, P-Chk2) correlated with immunoblot data for irradiated fibroblasts, whereas only γH2AX and P-Chk2 correlated with immunoblot data in melanoma cell lines. Melanoma cell lines displayed substantial variation in γH2AX and P-Chk2 expression, and P-Chk2 expression was significantly correlated with radioresistance. Moles, primary melanomas, and melanoma metastases in brain, lung and liver displayed substantial variation in γH2AX expression, similar to that observed in melanoma cell lines. Automated digital analysis of immunofluorescent images stained for DDR biomarkers may be useful for predicting tumor response to radiation and chemotherapy.

Indexed as

DNA DamageAtaxia Telangiectasia Mutated ProteinsBiomarkers, TumorCell Line, TumorCheckpoint Kinase 2FibroblastsHistonesHumansImage Processing, Computer-AssistedMelanomaNeoplasm MetastasisNevusSkinSkin NeoplasmsAtaxia Telangiectasia Mutated ProteinsBiomarkers, TumorCheckpoint Kinase 2CHEK2 protein, humanH2AX protein, humanHistonesautomated quantitative analysisDigital-image-analysisDNA damage responseimmunofluorescenceionizing radiationmelanomaP-Chk2γH2AX

Identifiers

PMID24309508
PMCPMC3935445
OpenAlexW1991427152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.